| Literature DB >> 26657110 |
Jiangli Di1,2, Shannon Rutherford2, Jiuling Wu1, Bo Song1, Lan Ma1, Jingyi Chen1, Cordia Chu2.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2015 PMID: 26657110 PMCID: PMC4682831 DOI: 10.1371/journal.pone.0144819
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic characteristics of women among different regions (n = 308) (From Chi-square test).
| Characteristics | Most developed regions (N = 96) | Developed regions (N = 106) | Less developed regions (N = 106) | Total frequency |
|
|
|---|---|---|---|---|---|---|
| Age | ||||||
| <34 | 0(0.0) | 30(28.3) | 2(1.9) | 32(10.4) | 73.717 | <0.001 |
| 35–44 | 28(29.2) | 44(41.5) | 34(32.1) | 106(34.4) | ||
| 45–54 | 54(56.2) | 24(22.6) | 48(45.3) | 126(40.9) | ||
| 55–64 | 14 (14.6) | 8(7.5) | 22(20.8) | 44(14.3) | ||
| Education level | ||||||
| Junior college or higher | 8(8.3) | 10(9.4) | 0(0.0) | 18(5.8) | 79.585 | <0.001 |
| Senior/Technical school | 10(10.4) | 12(11.3) | 10(9.4) | 32(10.4) | ||
| Junior high school | 68(70.8) | 72(67.9) | 36(34.0) | 176(57.1) | ||
| Primary school or Illiteracy | 10(10.4) | 12(11.3) | 60(56.6) | 82(26.6) | ||
| Received advice from doctors | ||||||
| Yes | 38(39.6) | 56(52.8) | 30(28.3) | 124(40.3) | 13.284 | 0.001 |
| No | 58(60.4) | 50(47.2) | 76(71.7) | 184(59.7) |
Differences in knowledge scores and rate among women with different educational levels (n = 308) (From ANOVA and Chi-square test).
| Educational level | Total Knowledge | Risk Factors of CC | CC prevention | Clinical symptoms of CC | Benefits of screening | Understanding of positive results | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | KR | Score | KR | Score | KR | Score | KR | Score | KR | Score | KR | |
| X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | |
| Junior college or higher | 19.11±6.85 | 10(55.6) | 3.56±1.54 | 6(33.3) | 4.00±1.82 | 8(44.4) | 4.44±2.62 | 8(44.4) | 2.00±1.08 | 12(66.7) | 5.11±1.84 | 6(33.3) |
| Senior/Technical school | 15.06±7.77 | 6(18.8) | 1.94±1.70 | 4(12.5) | 2.06±2.29 | 6(18.8) | 3.50±2.59 | 8(25.0) | 1.44±1.34 | 18(56.3) | 6.13±1.86 | 16(50.0) |
| Junior high school | 14.16±7.93 | 40(22.7) | 1.93±1.97 | 28(15.9) | 2.01±2.11 | 34(19.3) | 3.02±2.42 | 38(21.6) | 1.74±1.22 | 104(59.1) | 5.45±2.47 | 102(58.0) |
| Primary school or illiteracy | 7.61±5.67 | 4(4.9) | 0.71±1.28 | 4(4.9) | 0.63±1.17 | 2(2.4) | 1.76±1.19 | 2(2.4) | 1.05±1.20 | 36(43.9) | 3.46±2.30 | 14(17.1) |
|
| <0.001 | <0.001 | <0.001 | 0.005 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.099 | <0.001 | - |
KR: Knowledgeable Rate;
, indicates a statistically significance significant difference between junior college or higher and senior/technical school;
indicates a statistically significance significant difference between junior college or higher and junior high school;
indicates a statistically significance significant difference between junior college or higher and primary school or illiteracy;
indicates a statistically significance significant difference between senior/technical school and primary school or illiteracy;
represent there is a statistical significance between junior high school and primary school or illiteracy.
For ANOVA test, p <0.05 indicates a statistically significant difference between subgroups; for Chi-square test, p <0.0125 indicates a statistically significant difference between subgroups.
* Fisher’s Exact Test
Differences in knowledge scores across disparate regions (n = 308) (From ANOVA and Chi-square test).
| Regions | Total Knowledge | Risk Factors of CC | CC prevention | Clinical symptoms of CC | Benefits of screening | Understanding of positive results | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | KR | Score | KR | Score | KR | Score | KR | Score | KR | Score | KR | |
| X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | |
| Most developed | 19.38±8.19 | 48(50.0) | 3.00±2.13 | 34(35.4) | 3.56±2.07 | 40(417) | 4.771±2.67 | 46(47.9) | 2.15±1.20 | 70(72.9) | 5.90±2.31 | 58(60.4) |
| Developed | 11.87±6.34 | 12(11.35) | 1.40±1.66 | 8(7.5) | 1.49±1.83 | 10(9.4) | 2.26±1.73 | 10(9.4) | 1.57±1.18 | 60(56.6) | 5.15±2.45 | 50(47.2) |
| Less developed | 7.77±4.55 | 0(0.0) | 0.83±1.08 | 0(0.0) | 0.42±0.69 | 0(0.0) | 1.60±0.90 | 0(0.0) | 0.96±1.12 | 40(37.7) | 3.960±2.40 | 30(28.3) |
|
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
KR: Knowledgeable Rate;
, indicates a statistically significance significant difference between most developed and developed regions;
indicates a statistically significance significant difference between most developed and less developed regions;
indicates a statistically significance significant difference between developed and less developed regions.
For ANOVA test, p<0.05 indicates a statistically significant difference between subgroups; for Chi-square test, p<0.0167 indicates a statistically significant difference between subgroups.
Differences in knowledge scores among women who received advice from doctors or not (n = 308) (From t-test).
| Received advice from doctors | Total Knowledge | Risk Factors of CC | CC prevention | Clinical symptoms of CC | Benefits of screening | Understanding of positive results | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | KR | Score | KR | Score | KR | Score | KR | Score | KR | Score | KR | |
| X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | |
| Yes | 15.66±8.09 | 38(30.6) | 2.27±2.10 | 28(22.6) | 2.45±2.23 | 32(25.8) | 3.58±2.44 | 34(27.4) | 1.94±1.17 | 84(67.7) | 5.42±2.33 | 66(53.2) |
| No | 10.87±7.36 | 22(12.0) | 1.32±1.63 | 14(7.6) | 1.30±1.78 | 18(9.8) | 2.30±2.06 | 22(12.0) | 1.27±1.25 | 86(46.7) | 4.67±2.58 | 72(39.1) |
|
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.001 | 0.006 | <0.001 | 0.010 | 0.015 |
KR: Knowledgeable Rate; P<0.05 indicates a statistically significant difference between subgroups
Differences in Knowledge Scores and Rate among women of different age groups (n = 308) (From ANOVA and Chi-square test).
| Age group | Total Knowledge | Risk Factors of CC | CC prevention | Clinical symptoms of CC | Benefits of screening | Understanding of positive results | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | KR | Score | KR | Score | KR | Score | KR | Score | KR | Score | KR | |
| X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | X±SD | n(%) | |
| <34 | 15.37±5.15 | 6(18.8) | 2.06±1.81 | 4(12.5) | 2.13±1.93 | 6(18.8) | 2.69±1.79 | 4(12.5) | 2.38±0.94 | 26(81.3) | 6.13±1.93 | 24(75.0) |
| 35–44 | 13.23±8.17 | 24(22.6) | 1.81±2.01 | 16(15.1) | 1.85±2.13 | 20(18.9) | 2.98±2.46 | 24(22.6) | 1.70±1.23 | 66(62.3) | 4.89±2.46 | 42(39.6) |
| 45–54 | 12.79±8.56 | 26(20.6) | 1.71±1.91 | 20(15.9) | 1.84±2.21 | 22(17.5) | 3.00±2.46 | 26(20.6) | 1.32±1.28 | 56(44.4) | 4.92±2.46 | 56(44.4) |
| 55–64 | 9.91±6.98 | 4(9.1) | 1.14±1.47 | 2(4.5) | 1.09±1.46 | 2(4.5) | 2.00±1.56 | 2(4.5) | 1.18±1.17 | 22(50.0) | 4.50±2.95 | 16(36.4) |
|
| 0.024 | 0.289 | 0.140 | 0.253 | 0.113 | 0.154 | 0.072 | 0.044 | <0.001 | 0.001 | 0.036 | 0.003 |
KR: Knowledgeable Rate.
indicates a statistically significant difference between age groups <34 and 35–44;
indicates a statistically significant difference between age groups <34 and 45–54;
indicates a statistically significant difference between age groups <34 and 55–64;
indicates a statistically significant difference between age groups 35–44 and 45–54;
indicates a statistically significant difference between age groups 35–44 and 55–64.
For ANOVA test, p <0.05 indicates a statistically significant difference between subgroups; for Chi-square test, p <0.0125 indicates a statistically significant difference between subgroups.
* Fisher’s Exact Test
Frequency of correct answer for items about CC among women in different regions (n = 308) (From Chi-square test).
| Items | Most developed regions (N = 96) | Developed regions (N = 106) | Less developed regions (N = 106) | Total frequency |
|
|
|---|---|---|---|---|---|---|
|
| ||||||
| Having multiple partners or partners who have multiple partners | 56(58.3) | 30(28.3) | 8(7.5) | 94(30.5) | 61.649 | <0.001 |
| Had sexual intercourse and children at a young age | 54(56.3) | 24(22.6) | 38(35.8) | 116(37.7) | 24.463 | <0.001 |
| History of Sexually transmitted diseases | 54(56.3) | 22(20.8) | 2(1.2) | 78(25.3) | 80.510 | <0.001 |
| History of HPV infection | 34(35.4) | 6(5.7) | 0(0.0) | 40(13.0) | 63.595 | <0.001 |
| Aged 30–65 | 40(41.7) | 24(22.6) | 12(11.3) | 76(24.7) | 25.319 | <0.001 |
| Hormonal contraceptive use | 40(41.7) | 18(17.0) | 8(7.5) | 66(21.5) | 36.730 | <0.001 |
| Smoking | 10(10.4) | 24(22.6) | 20(18.9) | 54(17.5) | 5.406 | 0.067 |
|
| ||||||
| Reduce numbers of sexual partners | 54(56.3) | 20(18.9) | 4(3.8) | 78(25.3) | 76.919 | <0.001 |
| Late marriage and late childbirth | 48(50.0) | 6(5.7) | 2(1.9) | 56(18.2) | 95.426 | <0.001 |
| Using condom | 66(68.8) | 14(13.2) | 0(0.0) | 80(26.0) | 137.536 | <0.001 |
| No smoking | 12(12.5) | 22(20.8) | 4(3.8) | 38(12.3) | 14.134 | 0.001 |
| Having HPV vaccine before sexual debut | 26(27.1) | 2(1.9) | 0(0.0) | 28(9.1) | 54.861 | <0.001 |
| Prompt treatment of STIs | 66(68.8) | 36(34.0) | 0(0.0) | 102(33.1) | 107.551 | <0.001 |
| CC screening | 70(72.9) | 58(54.7) | 34(32.1) | 162(52.6) | 33.993 | <0.001 |
|
| ||||||
| Post-menopausal bleeding | 58(60.4) | 16(15.1) | 4(3.8) | 78(25.3) | 94.412 | <0.001 |
| Abnormal vaginal discharge | 62(64.6) | 32(30.2) | 12(11.3) | 106(34.4) | 64.595 | <0.001 |
| Vulvar itching or burning sensation (Choose “No”) | 48(50.0) | 82(77.4) | 106(100.0) | 236(76.6) | 70.360 | <0.001 |
| Inter-menstrual bleeding | 62(64.6) | 22(20.8) | 16(15.1) | 100(32.5) | 66.383 | <0.001 |
| Vaginal discharge | 32(33.3) | 10(9.4) | 0(0.0) | 42(13.6) | 49.952 | <0.001 |
| Pelvic pain | 40(41.7) | 24(22.6) | 0(0.0) | 64(20.8) | 53.470 | <0.001 |
| Bleeding after sexual intercourse, douching, or a pelvic exam | 70(72.9) | 20(18.9) | 12(11.3) | 102(33.1) | 101.106 | <0.001 |
| Urinary frequency, urgency | 30(31.3) | 8(7.5) | 0(0.0) | 38(12.3) | 48.916 | <0.001 |
| Longer or heavier menstrual periods | 56(58.3) | 26(24.5) | 20(18.9) | 102(33.1) | 40.806 | <0.001 |
|
| ||||||
| Early detection of cervical precancerous lesions or cancer | 74(77.1) | 68(64.2) | 48(45.3) | 190(61.7) | 21.970 | <0.001 |
| Early diagnosis of cervical precancerous lesions or cancer | 60(62.5) | 30(28.3) | 12(11.3) | 102(33.1) | 61.264 | <0.001 |
| Early treatment of cervical precancerous lesions or cancer | 72(75.0) | 68(64.2) | 42(39.6) | 182(59.1) | 27.794 | <0.001 |
|
| ||||||
| Negative screening result means cervix without any lesion, needing no more screening (Choose “No”) | 78(81.3) | 82(77.4) | 52(49.1) | 212(68.8) | 29.814 | <0.001 |
| Negative screening result means cervix without any lesion, but still needing screening every 2–3 years | 62(64.6) | 66(62.3) | 44(41.5) | 172(55.8) | 13.578 | 0.001 |
| Positive screening result means suffering from CC(Choose “No”) | 50(52.1) | 38(35.8) | 12(11.3) | 100(32.5) | 39.019 | <0.001 |
| Positive screening result means suffering from early stage cervical carcinoma (Choose “No”) | 48(50.0) | 34(32.1) | 10(9.4) | 92(29.9) | 39.949 | <0.001 |
| Positive screening result means suffering from cervical precancerous lesions (Choose “No”) | 44(45.8) | 18(17.0) | 8(7.5) | 70(22.7) | 45.086 | <0.001 |
| Positive screening result means there is cervical lesion, it needs further diagnosis | 76(79.2) | 64(60.4) | 40(37.7) | 180(58.4) | 35.853 | <0.001 |
| CC is an incurable disease (Choose “No”) | 70(72.9) | 90(84.9) | 88(83.0) | 248(80.5) | 5.260 | 0.072 |
| CC is a disease can be treated | 82(85.4) | 86(81.1) | 84(79.2) | 252(81.8) | 1.341 | 0.511 |
| CC is curable disease | 56(58.3) | 68(64.2) | 82(77.4) | 206(66.9) | 8.777 | 0.012 |
Logistic Regression Analysis of Factors Associated with total and sectional knowledge rate (N = 308).
| Influence factors | B | Wald |
| OR | 95%CI |
|---|---|---|---|---|---|
|
| |||||
| Regions | 3.269 | 38.850 | 0.000 | 26.279 | 9.402~73.452 |
| Receive advice from doctors | 1.547 | 14.323 | 0.000 | 4.696 | 2.108~10.462 |
| Education | 0.490 | 3.550 | 0.060 | 1.632 | 0.980~2.718 |
| Age | -0.061 | 5.055 | 0.025 | 0.941 | 0.892~0.992 |
|
| |||||
| Regions | 3.061 | 28.760 | 0.000 | 21.342 | 6.973~65.318 |
| Receive advice from doctors | 1.424 | 11.349 | 0.001 | 4.154 | 1.814~9.513 |
| Education | .090 | 0.110 | 0.740 | 1.095 | 0.641~1.868 |
| Age | -.071 | 5.672 | 0.017 | 0.931 | 0.878~0.987 |
|
| |||||
| Regions | 3.217 | 32.297 | 0.000 | 24.949 | 8.227~75.659 |
| Receive advice from doctors | 1.321 | 10.608 | 0.001 | 3.747 | 1.692~8.296 |
| Education | 0.480 | 3.452 | 0.063 | 1.616 | 0.974~2.683 |
| Age | -0.079 | 7.171 | 0.007 | 0.924 | 0.873~0.979 |
|
| |||||
| Regions | 3.475 | 37.926 | 0.000 | 32.311 | 10.690~97.661 |
| Receive advice from doctors | 1.289 | 10.169 | 0.001 | 3.628 | 1.643~8.011 |
| Education | 0.576 | 4.959 | 0.026 | 1.778 | 1.071~2.951 |
| Age | -0.824 | 36.816 | 0.006 | 0.439 | 0.243~0.790 |
|
| |||||
| Regions | 0.754 | 20.977 | 0.000 | 2.125 | 1.539 |
| Receive advice from doctors | 0.748 | 8.610 | 0.003 | 2.113 | 1.282 |
| Education | -0.056 | 0.106 | 0.745 | 0.945 | 0.675~1.325 |
| Age | -0.033 | 5.104 | 0.024 | 0.967 | 0.939~0.996 |
|
| |||||
| Regions | 0.622 | 14.823 | 0.000 | 1.862 | 1.357~2.555 |
| Receive advice from doctors | 0.430 | 3.032 | 0.082 | 1.538 | 0.947~2.496 |
| Education | 0.184 | 1.166 | 0.280 | 1.202 | 0.861~1.678 |
| Age | -0.024 | 2.687 | 0.101 | 0.977 | 0.949~1.005 |
a:0 = less developed, 1 = developed, 2 = most developed;
b:0 = no,1 = yes;
c:0 = primary school or illiteracy, 1 = junior high school, 2 = senior/Technical school, 3 = junior college or higher